Renagel



Indications and Reactions:

Role Indications Reactions
Primary
Hyperphosphataemia 42.7%
Product Used For Unknown Indication 35.9%
Drug Use For Unknown Indication 13.5%
Renal Failure Chronic 1.3%
Hyperparathyroidism Secondary 1.1%
Constipation 1.1%
Hyperkalaemia 0.7%
Hypertension 0.6%
Fabry's Disease 0.5%
Pain 0.4%
Nephrogenic Anaemia 0.3%
Anaemia 0.3%
Vitamin D 0.3%
Hypocalcaemia 0.2%
Atrial Fibrillation 0.2%
Back Pain 0.2%
Blood Phosphorus Abnormal 0.2%
Coronary Artery Disease 0.2%
Essential Hypertension 0.2%
Gout 0.2%
Muscular Weakness 19.7%
Death 14.0%
Large Intestine Perforation 6.3%
Intestinal Perforation 6.0%
Vomiting 6.0%
Gastrointestinal Haemorrhage 5.4%
Intestinal Obstruction 4.8%
Constipation 4.1%
Sepsis 3.8%
Melaena 3.2%
Treatment Noncompliance 3.2%
Cerebrovascular Accident 2.9%
Myocardial Infarction 2.9%
Peritonitis 2.9%
Vascular Calcification 2.9%
Abdominal Pain Upper 2.5%
Diverticulitis 2.5%
Hyperphosphataemia 2.5%
Hypertension 2.2%
Shock 2.2%
Secondary
Hyperphosphataemia 33.8%
Product Used For Unknown Indication 30.4%
Drug Use For Unknown Indication 18.4%
Constipation 4.9%
Renal Failure Chronic 2.8%
Hyperkalaemia 1.8%
Hyperparathyroidism Secondary 1.6%
Prophylaxis 1.1%
Myocardial Ischaemia 1.1%
Haemodialysis 0.8%
Ill-defined Disorder 0.7%
Essential Hypertension 0.4%
Diabetic Neuropathy 0.3%
Epilepsy 0.3%
Vitamin D 0.3%
Type 2 Diabetes Mellitus 0.3%
Anaemia 0.2%
Atrial Tachycardia 0.2%
Chronic Myeloid Leukaemia 0.2%
Coronary Artery Disease 0.2%
Muscular Weakness 13.7%
Shock 12.0%
Large Intestine Perforation 9.7%
Melaena 9.7%
Vascular Calcification 7.4%
Constipation 4.6%
Hyperphosphataemia 4.0%
Stillbirth 4.0%
Diverticulitis 3.4%
Intra-uterine Death 3.4%
Vomiting 3.4%
Weight Increased 3.4%
Anaphylactic Reaction 2.9%
Infectious Peritonitis 2.9%
Neutropenia 2.9%
Peritonitis 2.9%
Sciatica 2.9%
Anaemia 2.3%
Gastrointestinal Perforation 2.3%
Hypocholesterolaemia 2.3%
Concomitant
Drug Use For Unknown Indication 32.5%
Product Used For Unknown Indication 30.5%
Nuclear Magnetic Resonance Imaging 9.4%
Hypertension 3.5%
Angiogram 3.2%
Hyperparathyroidism Secondary 2.7%
Peritoneal Dialysis 2.3%
Hyperphosphataemia 1.8%
Nuclear Magnetic Resonance Imaging Brain 1.8%
Renal Failure Chronic 1.7%
Dialysis 1.5%
Pain 1.5%
Prophylaxis 1.2%
Anaemia 1.2%
Imaging Procedure 1.1%
Multiple Myeloma 0.8%
Thrombosis Prophylaxis 0.8%
Haemodialysis 0.8%
Diabetes Mellitus 0.7%
Nuclear Magnetic Resonance Imaging Abdominal 0.7%
Vomiting 23.1%
Skin Tightness 10.9%
Nephrogenic Systemic Fibrosis 7.2%
Therapeutic Response Decreased 7.1%
Weight Decreased 5.0%
Death 4.6%
Skin Induration 4.0%
Thrombocytopenia 4.0%
Skin Ulcer 3.5%
Sepsis 3.4%
Peritonitis 3.3%
Pyrexia 3.1%
Tremor 3.0%
Pain 2.9%
Nausea 2.8%
Renal Failure 2.7%
Renal Failure Chronic 2.7%
Peritonitis Bacterial 2.6%
Unresponsive To Stimuli 2.1%
Oedema Peripheral 2.0%
Interacting
Product Used For Unknown Indication 66.7%
Arthritis Fungal 8.3%
Atrial Fibrillation 8.3%
Hyperphosphataemia 8.3%
Prophylaxis Against Gastrointestinal Ulcer 4.2%
Renal Failure Chronic 4.2%
Fungal Infection 66.7%
Pericardial Haemorrhage 33.3%